These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 524618)

  • 1. Inhibition of normal plasma lipases by serum from chronic renal failure patients.
    Crawford GA; Savdie E; Stewart JH; Mahony JF
    Trans Am Soc Artif Intern Organs; 1979; 25():426-30. PubMed ID: 524618
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-released plasma lipases in chronic renal failure and after renal transplantation.
    Crawford GA; Savdie E; Stewart JH
    Clin Sci (Lond); 1979 Aug; 57(2):155-65. PubMed ID: 233952
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertriglyceridemia in chronic nonnephrotic renal failure.
    Gutman RA; Shalhoub RJ; Wade AD; O'Connell JM; Recant L
    Am J Clin Nutr; 1973 Feb; 26(2):165-72. PubMed ID: 4574031
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK; Pasternack A; Vänttinen T; Ehnholm C; Nikkilä EA
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activities of 2 plasma lipases and serum high density lipoprotein after heparin injection].
    Wu CZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Jun; 12(2):144-6. PubMed ID: 6489142
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of furosemide on the lipid abnormalities in chronic renal failure.
    Pasternack A; Leino T; Solakivi-Jaakkola T; Huttunen JK; Ehnholm C
    Acta Med Scand; 1983; 214(2):153-7. PubMed ID: 6624545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism.
    Applebaum-Bowden D; Goldberg AP; Hazzard WR; Sherrard DJ; Brunzell JD; Huttunen JK; Nikkila EA; Ehnholm C
    Metabolism; 1979 Sep; 28(9):917-24. PubMed ID: 481217
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective protamine sulphate inactivation of lipoprotein lipase and hepatic lipase in human post-heparin plasma: specific lipase levels in normals and in type I hyperlipoproteinaemia.
    Berger GM; Abraham PR
    Clin Chim Acta; 1977 Dec; 81(3):219-28. PubMed ID: 923094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
    Pasternack A; Vänttinen T; Solakivi T; Kuusi T; Korte T
    Clin Nephrol; 1987 Apr; 27(4):163-8. PubMed ID: 3555908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-heparin triacylglycerol lipases in ovine plasma.
    Tume RK; Thornton RF; Johnson GW
    Aust J Biol Sci; 1988; 41(2):215-21. PubMed ID: 3270309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and lipoprotein lipases selectively assayed in postheparin plasma.
    Henderson AD; Richmond W; Elkeles RS
    Clin Chem; 1993 Feb; 39(2):218-23. PubMed ID: 8432009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a fluorescent radiolabeled triacylglycerol as a substrate for lipoprotein lipase and hepatic triglyceride lipase.
    Dousset N; Negre A; Salvayre R; Rogalle P; Dang QQ; Douste-Blazy L
    Lipids; 1988 Jun; 23(6):605-8. PubMed ID: 3172990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of human tissue and post-heparin plasma triglyceride lipases.
    Klose G; De Grella R; Greten H
    Atherosclerosis; 1976; 25(2-3):175-82. PubMed ID: 1008906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and extrahepatic triglyceride lipase activity in uraemic patients on chronic haemodialysis.
    Bolzano K; Krempler F; Sandhofer F
    Eur J Clin Invest; 1978 Oct; 8(5):289-93. PubMed ID: 103720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of postheparin lipolytic activity in uremia and its relationship to hypertriglyceridemia.
    Boyer JL; Scheig RL
    Proc Soc Exp Biol Med; 1970 Jul; 134(3):603-5. PubMed ID: 5431345
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid metabolism disorders in chronic kidney failure].
    Lacour B; Roullet JB; Drueke T
    Nephrologie; 1983; 4(2):75-83. PubMed ID: 6348572
    [No Abstract]   [Full Text] [Related]  

  • 17. [Abnormal serum VLDL-IDL contents and changes in PHLA (LPH and H-TGL activities) in patients on hemodialysis].
    Yukawa S; Morishita S; Miyai T; Maeda T; Takahashi T; Kinoshita M; Miura K; Mune M; Yamada Y; Nomoto H
    Nihon Jinzo Gakkai Shi; 1983 Jun; 25(6):717-22. PubMed ID: 6663834
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.
    Cheung AK; Parker CJ; Ren K; Iverius PH
    Kidney Int; 1996 May; 49(5):1360-71. PubMed ID: 8731101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
    Asayama K; Ito H; Nakahara C; Hasegawa A; Kato K
    Pediatr Res; 1984 Aug; 18(8):783-8. PubMed ID: 6382139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.